fda compounding semaglutide news september 2025 The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing FDA and Novo Nordisk Warned
Description
Abstract Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide
Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK, et al
Colonoscopy is the gold standard for colorectal cancer screening
El monitoreo regular por un profesional de la salud es esencial para optimizar los beneficios y minimizar los riesgos de estos tratamientos
Sustainable weight loss is most likely to be achieved by combining GLP-1 therapy with healthy habits like a nutritious, balanced diet, regular exercise, and adequate sleep
